ReviewCancer biology & medicine2015
Geriatric oncology: problems with under-treatment within this population.
Review in Cancer biology & medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic identification of mutations and copy number alterations associated with cancer patient prognosis.eLife · 2018Pooled it
- Maximal resection improves survival in MGMT methylated very elderly glioblastoma patients.Journal of neuro-oncology · 2026Article
- The role of neoadjuvant therapy in elderly patients with T1b-T2N + esophageal cancer: a population-based cohort study.Discover oncology · 2026Article
- Achieving treatment goals in older breast cancer patients receiving neoadjuvant chemotherapy.Scientific reports · 2025Article
- Article
- Global, Regional, and National Burden and Trends of Female Cancers Among the Elderly Women (≥60 Years Old): An Analysis Based on the 2021 Global Burden of Disease Study.International journal of women's health · 2025Article
- Harnessing Radionuclides: Unveiling the Promising Role of Radiopharmaceuticals in Cancer Theranostics and Palliative Care.Current radiopharmaceuticals · 2025Review
- Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis.Cancers · 2024Article
- Abemaciclib for the Treatment of HR+HER2- Metastatic Breast Cancer: An Institutional Experience.Cancers · 2024Article
- Impact of Medical Specialties on Diagnostic and Therapeutic Management of Elderly Cancer Patients.Geriatrics (Basel, Switzerland) · 2023Article
- Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter?Journal of cancer research and clinical oncology · 2023Article
- Geriatric assessment in the older adult with genitourinary cancer: A narrative review.Frontiers in oncology · 2023Review
- Neoadjuvant systemic therapy in geriatric breast cancer patients: a National Cancer Database (NCDB) analysis.Breast cancer research and treatment · 2022Review
- Challenges in Geriatric Oncology-A Surgeon's Perspective.Current oncology (Toronto, Ont.) · 2022Review
- Revisiting surgical management of breast cancer in a geriatric population.Revista da Associacao Medica Brasileira (1992) · 2022Article
- Prevalence and risk factors of preoperative frailty in Chinese elderly inpatients with gastric and colorectal cancer undergoing surgery: a single-center cross-sectional study using the Groningen Frailty Indicator.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022Article
- Yttrium-90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study.Hepatology (Baltimore, Md.) · 2021Article
- Physicians' decreased tendency to choose palliative care for patients with advanced dementia between 1999 and 2015.BMC palliative care · 2021Article
- Patients 80 + have similar medication initiation rates to those aged 50-79 in Ontario FLS.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021Article
- Real‑world challenge for clinicians treating advanced gastroesophageal adenocarcinoma (Review).International journal of oncology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We are currently faced with an aging population, which is rapidly growing worldwide. Two thirds of cancer occurs in the over 65-year age group. Societal conceptions from the past have created ageist stereotypes; old age is associated with frailty and the elderly are perceived to be destined for deterioration and loss of independence. Cancer within the elderly is also subject to these stereotypes, with elderly cancer patients considered by some not as likely to recover as younger patients with cancer. We summarise and review the current concerns regarding elderly management and treatments utilised for the management of oncological disease in the elderly, and discuss the impact of under-treatment within this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.